ANI Pharmaceuticals Launches Nitazoxanide Tablets 500 Mg
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia.
Nikhil Lalwani, President and Chief Executive Officer of the company stated that the launch of Nitazoxanide Tablets aligns with their purpose of 'Serving Patients, Improving Lives'.
Notably, based on December 2024 moving annual total IQVIA data, total U.S. annual sales for Nitazoxanide Tablets stood at approximately $36.1 million.
In the pre-market hours, ANI's stock is trading at $63.22, down 1.56 percent on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.